Российская вакцина от рака успешно прошла доклинические испытания

The next stage is testing on volunteers

In Russia, preclinical trials of a cancer vaccine have been completed. This was announced by Academician of the Russian Academy of Sciences Andrey Kaprin.

The oncovaccine was created using mRNA technology. The essence of the drug lies in taking tumor material to analyze its features. Then, a tumor passport is created for further use of the data in personalizing the vaccine.

We have passed the preclinical stage. Now a letter has been sent to the Ministry of Health for permission to conduct the first phase of testing.
Andrey Kaprin, Academician of the Russian Academy of Sciences

As soon as the department gives permission, the trials will continue on volunteers. The selection of participants will be carried out by specialists.

Earlier www1.ru reported that in Russia they created a biocomposite to fight melanoma.

Read materials on the topic:

The Russian application for detecting skin cancer "ProRodinki" will be launched in polyclinics

Experimental neutron capture therapy on the TPU reactor: new horizons in the fight against cancer in animals

Cancer defeated?: Russia has developed a revolutionary vaccine against all types of cancer